227 related articles for article (PubMed ID: 28771231)
1. FGFR1 is critical for the anti-endothelial mesenchymal transition effect of N-acetyl-seryl-aspartyl-lysyl-proline via induction of the MAP4K4 pathway.
Li J; Shi S; Srivastava SP; Kitada M; Nagai T; Nitta K; Kohno M; Kanasaki K; Koya D
Cell Death Dis; 2017 Aug; 8(8):e2965. PubMed ID: 28771231
[TBL] [Abstract][Full Text] [Related]
2. βklotho is essential for the anti-endothelial mesenchymal transition effects of N-acetyl-seryl-aspartyl-lysyl-proline.
Gao R; Kanasaki K; Li J; Kitada M; Okazaki T; Koya D
FEBS Open Bio; 2019 May; 9(5):1029-1038. PubMed ID: 30972974
[TBL] [Abstract][Full Text] [Related]
3. Endothelial FGFR1 (Fibroblast Growth Factor Receptor 1) Deficiency Contributes Differential Fibrogenic Effects in Kidney and Heart of Diabetic Mice.
Li J; Liu H; Srivastava SP; Hu Q; Gao R; Li S; Kitada M; Wu G; Koya D; Kanasaki K
Hypertension; 2020 Dec; 76(6):1935-1944. PubMed ID: 33131311
[TBL] [Abstract][Full Text] [Related]
4. FGFR1 is essential for N-acetyl-seryl-aspartyl-lysyl-proline regulation of mitochondrial dynamics by upregulating microRNA let-7b-5p.
Hu Q; Li J; Nitta K; Kitada M; Nagai T; Kanasaki K; Koya D
Biochem Biophys Res Commun; 2018 Jan; 495(3):2214-2220. PubMed ID: 29269295
[TBL] [Abstract][Full Text] [Related]
5. The Interaction of Apelin and FGFR1 Ameliorated the Kidney Fibrosis through Suppression of TGF
Gao R; Wu Y; Yang Q; Chen L; Chen J; Wang B; Liu Z; Jin J; Li J; Wu G
Oxid Med Cell Longev; 2023; 2023():5012474. PubMed ID: 36785790
[TBL] [Abstract][Full Text] [Related]
6. N-acetyl-seryl-aspartyl-lysyl-proline inhibits diabetes-associated kidney fibrosis and endothelial-mesenchymal transition.
Nagai T; Kanasaki M; Srivastava SP; Nakamura Y; Ishigaki Y; Kitada M; Shi S; Kanasaki K; Koya D
Biomed Res Int; 2014; 2014():696475. PubMed ID: 24783220
[TBL] [Abstract][Full Text] [Related]
7. Effect of Antifibrotic MicroRNAs Crosstalk on the Action of N-acetyl-seryl-aspartyl-lysyl-proline in Diabetes-related Kidney Fibrosis.
Srivastava SP; Shi S; Kanasaki M; Nagai T; Kitada M; He J; Nakamura Y; Ishigaki Y; Kanasaki K; Koya D
Sci Rep; 2016 Jul; 6():29884. PubMed ID: 27425816
[TBL] [Abstract][Full Text] [Related]
8. [Anti-fibrotic role of AcSDKP through inhibition of P38MAPK pathway activity mediated transforming growth beta receptors in rat with silicosis].
Wei Z; Sun Y; Cheng H; Ma W; Xu H; Li Q; Zhang L; Wang R; Yang F
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2014 May; 32(5):340-7. PubMed ID: 25169087
[TBL] [Abstract][Full Text] [Related]
9. Treatment of traumatic brain injury in rats with N-acetyl-seryl-aspartyl-lysyl-proline.
Zhang Y; Zhang ZG; Chopp M; Meng Y; Zhang L; Mahmood A; Xiong Y
J Neurosurg; 2017 Mar; 126(3):782-795. PubMed ID: 28245754
[TBL] [Abstract][Full Text] [Related]
10. microRNA Crosstalk Influences Epithelial-to-Mesenchymal, Endothelial-to-Mesenchymal, and Macrophage-to-Mesenchymal Transitions in the Kidney.
Srivastava SP; Hedayat AF; Kanasaki K; Goodwin JE
Front Pharmacol; 2019; 10():904. PubMed ID: 31474862
[TBL] [Abstract][Full Text] [Related]
11. Antifibrotic effect of N-acetyl-seryl-aspartyl-lysyl-proline on bile duct ligation induced liver fibrosis in rats.
Zhang L; Xu LM; Chen YW; Ni QW; Zhou M; Qu CY; Zhang Y
World J Gastroenterol; 2012 Oct; 18(37):5283-8. PubMed ID: 23066324
[TBL] [Abstract][Full Text] [Related]
12. Combination treatment with N-acetyl-seryl-aspartyl-lysyl-proline and tissue plasminogen activator provides potent neuroprotection in rats after stroke.
Zhang L; Chopp M; Teng H; Ding G; Jiang Q; Yang XP; Rhaleb NE; Zhang ZG
Stroke; 2014 Apr; 45(4):1108-14. PubMed ID: 24549864
[TBL] [Abstract][Full Text] [Related]
13. FGF2 inhibits endothelial-mesenchymal transition through microRNA-20a-mediated repression of canonical TGF-β signaling.
Correia AC; Moonen JR; Brinker MG; Krenning G
J Cell Sci; 2016 Feb; 129(3):569-79. PubMed ID: 26729221
[TBL] [Abstract][Full Text] [Related]
14. Losartan inhibits endothelial-to-mesenchymal transformation in mitral valve endothelial cells by blocking transforming growth factor-β-induced phosphorylation of ERK.
Wylie-Sears J; Levine RA; Bischoff J
Biochem Biophys Res Commun; 2014 Apr; 446(4):870-5. PubMed ID: 24632204
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Angiotensin-Converting Enzyme Ameliorates Renal Fibrosis by Mitigating DPP-4 Level and Restoring Antifibrotic MicroRNAs.
Srivastava SP; Goodwin JE; Kanasaki K; Koya D
Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32085655
[TBL] [Abstract][Full Text] [Related]
16. [Regulating effect of N-acetyl-seryl-aspartyl-lysyl-proline on activation of c-jun N-terminal kinase pathway in rats with silicosis].
Wei ZQ; Yu WY; Feng HL; Ma WD; Li ZG; Xu H; Wang RM; Yang F
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2013 May; 31(5):335-40. PubMed ID: 23803521
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation of transforming growth factor beta signaling pathways by Notch in human endothelial cells.
Fu Y; Chang A; Chang L; Niessen K; Eapen S; Setiadi A; Karsan A
J Biol Chem; 2009 Jul; 284(29):19452-62. PubMed ID: 19473993
[TBL] [Abstract][Full Text] [Related]
18. Endothelial autophagy deficiency induces IL6 - dependent endothelial mesenchymal transition and organ fibrosis.
Takagaki Y; Lee SM; Dongqing Z; Kitada M; Kanasaki K; Koya D
Autophagy; 2020 Oct; 16(10):1905-1914. PubMed ID: 31965901
[TBL] [Abstract][Full Text] [Related]
19. MALAT1 Modulates TGF-β1-Induced Endothelial-to-Mesenchymal Transition through Downregulation of miR-145.
Xiang Y; Zhang Y; Tang Y; Li Q
Cell Physiol Biochem; 2017; 42(1):357-372. PubMed ID: 28535533
[TBL] [Abstract][Full Text] [Related]
20. [Effect of N-acetyl-seryl-aspartyl-lysyl-proline on regulation of expression of ras-raf-ERK1/2 signal transduction pathway in lung of rats with silicosis].
Tian JR; Yang F; Li DD; Zhang LJ; Wei ZQ; Feng HL; Li ZG; Wang RM
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2010 Oct; 28(10):760-5. PubMed ID: 21126429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
